3 completed, 3 unknown, 1 enrolling by invitation, 1 terminated. 2 Not applicable, 2 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Terminated 1 |
Follow Asbestosis: new trials by email Literature Review of Asbestosis trials Research Report on Asbestosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis Pirfenidone - Asbestosis | Not applicable | Unknown | Cairo University | 40 | 2024-02-01 | 2023-08-30 |
| Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages Blood collection, Blood sample - History of Exposure to Silica or Asbestosis, Positive Testing for ANA as a Marker of Systemic Autoimmune Diseases | Not applicable | Completed | Rennes University Hospital | 23 | 2021-03-31 | 2022-01-04 |
| Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders HP 3He, HP 129Xe, PFP - Lung Transplant, Lung Resection | Early Phase 1 | Terminated | Thunder Bay Regional Health Research Institute | 10 | 2020-11-10 | 2024-10-15 |
| The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial Nintedanib 150 MG [Ofev] - Pneumoconiosis Coal, Asbestosis | Phase 2 | Unknown | Holdsworth House Medical Practice | 100 | 2020-10-09 | 2021-02-10 |
| Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population Artichoke WPC - Asbestos Exposure | Phase 2 | Completed | Ontario Clinical Oncology Group (OCOG) | 3 | 2019-11-05 | 2021-07-13 |
| Oscillation Mechanics of the Respiratory System Asbestos Exposed: Early Diagnosis evaluated lung function - Asbestosis | Unknown | Rio de Janeiro State University | 2 | 2013-03-01 | 2015-07-01 | |
| The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | Enrolling by invitation | University of Edinburgh | 800 | 2007-06-14 | 2026-06-29 | |
| Specialized Center of Research in Occupational and Immunologic Lung Disease Lung Diseases, Obstructive, Asbestosis | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1972-06-01 | 2016-05-13 |
Lung Diseases, Interstitial (2) · Pulmonary Disease, Chronic Obstructive (2) · Silicosis (2) · Anthracosis (1) · Asthma (1) · Bronchiectasis (1) · Cystic Fibrosis (1) · Emphysema (1) · Hypertension, Pulmonary (1) · Idiopathic Pulmonary Fibrosis (1) · Lung Diseases, Obstructive (1) · Lung Neoplasms (1) · Mesothelioma (1) · Pneumoconiosis (1)
Lung Diseases (8) · Lung Injury (8) · Occupational Diseases (8) · Respiratory Tract Diseases (8) · Pneumoconiosis (7) · Lung Diseases, Interstitial (6) · Chronic Disease (2) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Adenoma (1) · Apnea (1) · Bronchial Diseases (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Blood Specimen Collection (1) · Sulfur Hexafluoride (1) · nintedanib (1) · perflutren (1) · pirfenidone (1)
Cairo University (1) · Holdsworth House Medical Practice (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Ontario Clinical Oncology Group (OCOG) (1) · Rennes University Hospital (1) · Rio de Janeiro State University (1) · Thunder Bay Regional Health Research Institute (1) · University of Edinburgh (1)
Canada (2) · Australia (1) · Brazil (1) · France (1)
Deborah Yates, A/Prof (1) · Hans Weill (1) · Marwa M Fouad, MD (1) · Mitchell S Albert, PhD (1) · Paola Muti (1)
PMID 33798455, PMID 35584850, PMID 35688625, PMID 35762891, PMID 35987988
P50HL015092 (1)